Hypoxia and expression of hypoxia-related proteins in acute myeloid leukemia

Leukemia Research

Volumn 35, Issue 5, 2011, Pages 573-574

  Fiegl, Michael ^a   Spiekermann, Karsten ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute myeloid leukemia; Hif1 ; Hypoxia; Prognosis

Indexed keywords

ANTHRACYCLINE; CYTARABINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; REACTIVE OXYGEN METABOLITE; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN C;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; CANCER SURVIVAL; CELL DIFFERENTIATION; EDITORIAL; GENE MUTATION; HEMATOPOIETIC STEM CELL; HUMAN; HYPOXIA; MICROVASCULATURE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; STROMA CELL; TUMOR MICROENVIRONMENT;

ANOXIA; BONE MARROW; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LEUKEMIA, MYELOID, ACUTE; MUTATION; PROTEINS;

EID: 79954625804     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2010.11.014     Document Type: Editorial

References (7)

1. Konopleva M., Andreeff M. Targeting the leukemia microenvironment. Curr Drug Targets 2007, 8(6):685-701.
2. Fiegl M., Samudio I., Clise-Dwyer K., Burks J.K., Mnjoyan Z., Andreeff M. CXCR4 expression and biologic activity in acute myeloid leukemia are dependent on oxygen partial pressure. Blood 2009, 113(7):1504-1512.
3. Abdel-Wahab O., Levine R. Metabolism and the leukemic stem cell. J Exp Med 2010, 207(4):677-680.
4. Parmar K., Mauch P., Vergilio J.A., Sackstein R., Down J.D. Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc Natl Acad Sci U S A. 2007, 104:5431-5436.
5. Wellmann S., Guschmann M., Griethe W., Eckert C., von Stackelberg A., Lottaz C., et al. Activation of HIF pathway in childhood ALL, prognostic implications of VEGF. Leukemia 2004, 18:926-933.
6. Deeb G., Vaughan M.M., McInnis I., Ford L.A., Sait S.N., Starostik P., Wetzler M., Mashtare T., Wang E.S. Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemia. Leukemia Res. 2011, 35:579-584.
7. Paschka P., Schlenk R.F., Gaidzik V.I., et al. IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication. J Clin Oncol 2010, 28(22):3636-3643.